Arca Biopharma Inc (ABIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 3,122 | 2,482 | 1,590 | 1,937 | 1,973 |
Operating Income | -3,122 | -2,482 | -1,590 | -1,937 | -1,973 |
Other Income | 444 | 473 | 501 | 513 | 493 |
Pre-tax Income | -2,678 | -2,009 | -1,089 | -1,424 | -1,480 |
Net Income Continuous | -2,678 | -2,009 | -1,089 | -1,424 | -1,480 |
Net Income | $-2,678 | $-2,009 | $-1,089 | $-1,424 | $-1,480 |
EPS Basic Total Ops | -0.18 | -0.14 | -0.08 | -0.10 | -0.10 |
EPS Basic Continuous Ops | -0.18 | -0.14 | -0.08 | -0.10 | -0.10 |
EPS Diluted Total Ops | -0.18 | -0.14 | -0.08 | -0.10 | -0.10 |
EPS Diluted Continuous Ops | -0.18 | -0.14 | -0.08 | -0.10 | -0.10 |
EPS Diluted Before Non-Recurring Items | -0.18 | -0.14 | -0.08 | -0.10 | -0.10 |
EBITDA(a) | $-3,110 | $-2,463 | $-1,567 | $-1,907 | $-1,944 |